Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Bariatric surgery980 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00032 | 35250014 | Ultrasound Q | Clinical Feasibility of Shear Wave Dispersion Slope for Noninvasive Diagnosis of Nonalcoholic Steatohepatitis in Patients With Morbid Obesity: Preliminary Results Using US Shear Wave Elastography. | 2022 | Details |
| A00073 | 35230526 | Langenbecks Arch Surg | Is there a role for preoperative liver reducing diet in hepatectomy? A systematic review. | 2022 | Details |
| A00221 | 35178496 | APL Bioeng | Development of resveratrol with thiolated alginate as a supplement to prevent nonalcoholic fatty liver disease (NAFLD). | 2022 | Details |
| A00224 | 35178085 | Gastroenterol Res Pract | The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran. | 2022 | Details |
| A00267 | 35160204 | J Clin Med | Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements. | 2022 | Details |
| A00360 | 35120767 | Med Clin (Barc) | Bariatric surgery and non-alcoholic fatty liver disease. | 2022 | Details |
| A00387 | 35107488 | Arq Bras Cir Dig | OBESITY AND SEVERE STEATOSIS: THE IMPORTANCE OF BIOCHEMICAL EXAMS AND SCORES. | 2022 | Details |
| A00446 | 35080048 | J Gastroenterol Hepatol | Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
| A00526 | 35053205 | Biomolecules | Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. | 2021 | Details |
| A00601 | 35034646 | Lipids Health Dis | The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery. | 2022 | Details |
| A00616 | 35027111 | J Am Coll Cardiol | Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week. | 2022 | Details |
| A00643 | 35016856 | Obes Res Clin Pract | High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up. | 2022 | Details |
| A00651 | 35014161 | Diabetes Obes Metab | The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment. | 2022 | Details |
| A00694 | 35000203 | Hepatology | Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. | 2022 | Details |
| A00723 | 34988895 | Obes Surg | Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States. | 2022 | Details |
| A00747 | 34981313 | Dig Dis Sci | Bariatric Surgery in NAFLD. | 2022 | Details |
| A00750 | 34980714 | J Nutr Sci Vitaminol (Tokyo) | Fasting, Nutrition and Weight Loss: An Approach to Refine Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00771 | 34973842 | Transplant Proc | Bariatric Surgery and Solid-Organ Transplantation. | 2021 | Details |
| A00857 | 34945016 | J Clin Med | Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review. | 2021 | Details |
| A00934 | 34924365 | J Obes Metab Syndr | Severe Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment. | 2021 | Details |
| A00956 | 34919684 | J Nutr | A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease-Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery. | 2022 | Details |
| A00984 | 34909896 | Rev Assoc Med Bras (1992) | Nonalcoholic fatty liver disease: scintigraphy in the diagnosis of steatohepatitis. | 2021 | Details |
| A01003 | 34905051 | J Clin Endocrinol Metab | Fibrogenesis marker PRO-C3 is higher in advanced liver fibrosis and improves in patients undergoing bariatric surgery. | 2022 | Details |
| A01045 | 34890093 | Liver Int | Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery. | 2021 | Details |
| A01059 | 34884755 | Int J Mol Sci | Role of ANGPTL8 in NAFLD Improvement after Bariatric Surgery in Experimental and Human Obesity. | 2021 | Details |
| A01183 | 34836332 | Nutrients | Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01215 | 34827579 | Biomolecules | Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms. | 2021 | Details |
| A01227 | 34822395 | Metabolites | Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics. | 2021 | Details |
| A01242 | 34816355 | Obes Surg | Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASH. | 2021 | Details |
| A01286 | 34802660 | Clin Liver Dis | Endoscopic Bariatric Interventions in Patients with Chronic Liver Disease. | 2021 | Details |
| A01326 | 34786549 | JHEP Rep | Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates. | 2021 | Details |
| A01392 | 34762779 | Arch Endocrinol Metab | Acoustic radiation force impulse elastography and liver fibrosis risk scores in severe obesity. | 2021 | Details |
| A01395 | 34762106 | JAMA | Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01396 | 34761883 | Minerva Med | Inflammatory-nutritional scores in the diagnosis of NASH and liver fibrosis. | 2021 | Details |
| A01410 | 34757198 | Clin Gastroenterol Hepatol | Longitudinal Changes in MR Elastography-based Biomarkers in Obese Patients Treated with Bariatric Surgery. | 2021 | Details |
| A01444 | 34743657 | Adipocyte | Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD. | 2021 | Details |
| A01483 | 34729904 | Obes Rev | Gut microbiota and related metabolites in the pathogenesis of nonalcoholic steatohepatitis and its resolution after bariatric surgery. | 2021 | Details |
| A01501 | 34722019 | Cureus | Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review. | 2021 | Details |
| A01507 | 34717726 | Trials | Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study). | 2021 | Details |
| A01513 | 34712528 | Cureus | An Emerging Facet of Diabetes Mellitus: The Nexus of Gastrointestinal Disorders. | 2021 | Details |
| A01588 | 34684510 | Nutrients | Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis. | 2021 | Details |
| A01724 | 34638880 | Int J Mol Sci | A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity. | 2021 | Details |
| A01770 | 34622555 | Diabetes Obes Metab | Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes. | 2021 | Details |
| A01789 | 34617207 | Obes Surg | Religious Fasting of Muslim Patients After Metabolic and Bariatric Surgery: a Modified Delphi Consensus. | 2021 | Details |
| A01838 | 34598315 | Immun Inflamm Dis | Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. | 2021 | Details |
| A01948 | 34557367 | Cureus | Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. | 2021 | Details |
| A01973 | 34546515 | Obes Surg | Changes in Total Homocysteine and Glutathione Levels After Laparoscopic Sleeve Gastrectomy in Children with Metabolic-Associated Fatty Liver Disease. | 2021 | Details |
| A01974 | 34546514 | Obes Surg | Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score-Matched Analysis. | 2021 | Details |
| A01987 | 34540134 | Kans J Med | Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease. | 2021 | Details |
| A02081 | 34511367 | Obes Res Clin Pract | Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study. | 2021 | Details |
| A02090 | 34509375 | Surg Obes Relat Dis | Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years. | 2021 | Details |
| A02104 | 34506234 | Adipocyte | A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. | 2021 | Details |
| A02117 | 34501231 | J Clin Med | Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies. | 2021 | Details |
| A02132 | 34494551 | JCI Insight | Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation. | 2021 | Details |
| A02185 | 34469884 | Dig Dis | Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm. | 2021 | Details |
| A02233 | 34450307 | Pharmacol Res | Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis. | 2021 | Details |
| A02261 | 34444807 | Nutrients | Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut-Liver Axis. | 2021 | Details |
| A02322 | 34419953 | Obes Facts | Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients. | 2021 | Details |
| A02348 | 34407548 | Exp Clin Endocrinol Diabetes | Hepatic Meteorin-like and Krüppel-like Factor 3 are Associated with Weight Loss and Liver Injury. | 2021 | Details |
| A02465 | 34362228 | J Clin Med | Association of Body Composition and Sarcopenia with NASH in Obese Patients. | 2021 | Details |
| A02478 | 34359642 | Cancers (Basel) | The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma. | 2021 | Details |
| A02490 | 34355282 | Metabolomics | Short-term changes in the serum metabolome after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. | 2021 | Details |
| A02527 | 34340957 | Endocrinol Diabetes Nutr (Engl Ed) | Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. | 2021 | Details |
| A02574 | 34326020 | Surg Obes Relat Dis | Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease. | 2021 | Details |
| A02586 | 34321990 | Prz Menopauzalny | Bariatric surgery: blessing or sometimes curse for the liver? | 2021 | Details |
| A02593 | 34321421 | J Pediatr Gastroenterol Nutr | Unhealthy Eating, Psychopathology, and Nonalcoholic Fatty Liver Disease in Youth Presenting for Bariatric Surgery. | 2021 | Details |
| A02608 | 34311133 | Clin Res Hepatol Gastroenterol | How will NAFLD change the liver transplant landscape in the 2020s? | 2021 | Details |
| A02654 | 34297346 | Curr Obes Rep | Endoscopic Procedures for Weight Loss. | 2021 | Details |
| A02780 | 34243194 | Semin Liver Dis | Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. | 2021 | Details |
| A02805 | 34234198 | Sci Rep | Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. | 2021 | Details |
| A02815 | 34231659 | Arq Gastroenterol | PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS. | 2021 | Details |
| A02892 | 34204274 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut-Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. | 2021 | Details |
| A02914 | 34199535 | J Pers Med | Target Therapies for NASH/NAFLD: From the Molecular Aspect to the Pharmacological and Surgical Alternatives. | 2021 | Details |
| A02941 | 34190166 | Medicine (Baltimore) | Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients. | 2021 | Details |
| A02982 | 34174416 | Nanomedicine | Circulating extracellular vesicles are a biomarker for NAFLD resolution and response to weight loss surgery. | 2021 | Details |
| A03004 | 34168277 | Int J Obes (Lond) | Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity. | 2021 | Details |
| A03006 | 34167531 | BMC Surg | Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study. | 2021 | Details |
| A03136 | 34118015 | Updates Surg | Liver transplantation and bariatric surgery: a new surgical reality: a systematic review of the best time for bariatric surgery. | 2021 | Details |
| A03246 | 34072995 | Metabolites | Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review. | 2021 | Details |
| A03270 | 34065140 | Children (Basel) | Update on Metabolic Bariatric Surgery for Morbidly Obese Adolescents. | 2021 | Details |
| A03334 | 34040322 | World J Gastroenterol | Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease. | 2021 | Details |
| A03349 | 34032283 | Eur J Clin Invest | Multiplying effects of COVID-19 lockdown on metabolic risk and fatty liver. | 2021 | Details |
| A03430 | 34002452 | Obes Rev | Bariatric surgery and the liver-Mechanisms, benefits, and risks. | 2021 | Details |
| A03441 | 33999371 | Eat Weight Disord | The predictive role of parathyroid hormone for non-alcoholic fatty liver disease based on invasive and non-invasive findings in candidates of bariatric surgery. | 2021 | Details |
| A03484 | 33987424 | Ann Transl Med | Non-alcoholic fatty liver diseases: current challenges and future directions. | 2021 | Details |
| A03499 | 33982243 | Obes Surg | Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study. | 2021 | Details |
| A03505 | 33978572 | Clin Liver Dis | Obesity Management of Liver Transplant Waitlist Candidates and Recipients. | 2020 | Details |
| A03544 | 33961941 | J Hepatol | Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression. | 2021 | Details |
| A03602 | 33935810 | Front Physiol | Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03621 | 33927697 | Front Endocrinol (Lausanne) | Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy. | 2021 | Details |
| A03703 | 33897617 | Front Endocrinol (Lausanne) | Mining Gut Microbiota From Bariatric Surgery for MAFLD. | 2021 | Details |
| A03730 | 33887358 | J Hepatol | Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis. | 2021 | Details |
| A03733 | 33885048 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study. | 2021 | Details |
| A03740 | 33882758 | Expert Rev Clin Pharmacol | Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease. | 2021 | Details |
| A03771 | 33869077 | Front Cell Infect Microbiol | The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats. | 2021 | Details |
| A03781 | 33865909 | J Hepatol | Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity. | 2021 | Details |
| A03851 | 33847141 | J Am Heart Assoc | Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis. | 2021 | Details |
| A03853 | 33846949 | Obes Surg | Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis. | 2021 | Details |
| A03857 | 33844174 | Obes Surg | Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study. | 2021 | Details |
| A03931 | 33813683 | Obes Surg | Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass. | 2021 | Details |